photo walkheader_zpsd5bunpmi.png

Category Archives: Medical Research

Three Things that Aren’t True About Pancreatic Cancer

“Half the lies they tell about me aren’t true.”    -Yogi Berra There are legitimate controversies in pancreatic cancer.  Often over time, the pendulum can swing to one side or the other of a scientific conflict – as new evidence supports a contention or not.  Sometimes, with a greater understanding of the complexity of an issue, […]

GVAX Immunotherapy and Hematologic Status in Pancreatic Cancer

As noted in an earlier blog, GVAX is a kind of vaccine that appears to work by enhancing “granulocyte-macrophage colony-stimulating factor” (GM-CSF) which in turn enhances white blood cells including monocytes that can somewhat freely move and have the ability to transform into so-called “professional” antigen-presenting cells such as macrophages and dendritic cells – which […]

FDA Grants Orphan Status for the CRS-207 Vaccine with GVAX Immunotherapy for Pancreatic Cancer

In an interesting step with intriguingly complex promise, the Office of Orphan Products Development of the U.S. Food and Drug Administration recently designated the immunotherapy CRS-207 as having orphan drug status for use in sequential combination with the GVAX Pancreas biologic for the treatment of pancreatic cancer (ductal adenocarcinoma of the pancreas). Both of these […]

Page 20 of 25« First...10...1819202122...Last »
Facebook
Facebook